http://orcid.org/0000-0002-6065-1476
Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Naoki Ichikawa, Ayataka Fujimoto, Tohru Okanishi, Keishiro Sato & Hideo Enoki. (2020) Efficacy and Safety of Epilepsy Surgery for Older Adult Patients with Refractory Epilepsy. Therapeutics and Clinical Risk Management 16, pages 195-199.
Read now
Read now
Articles from other publishers (18)
Haiyan Ma, Haitao Zhu, Fangqing Chen, Yiqing Yang, Xuefeng Qu, Honghao Xu, Lu Yang & Rui Zhang. (2023) Efficacy and safety of perampanel monotherapy in Chinese patients with focal‐onset seizures: A single‐center, prospective, real‐world observational study. Epilepsia Open 8:4, pages 1474-1483.
Crossref
Crossref
James Wheless, Robert T. Wechsler, Patricia Penovich, Eric Segal, Michael Chez, Antonietta Coppola, Anita Datta, Wendyl D'Souza, Imad Najm, Sheri Cappucci, Ricardo Sainz-Fuertes & Vicente Villanueva. (2023) Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: The PERMIT Extension study. Epilepsy & Behavior 147, pages 109369.
Crossref
Crossref
Song Ee Youn, Hoon-Chul Kang, Joon Soo Lee, Heung Dong Kim & Se Hee Kim. (2023) Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4–19 years with epilepsy: a real-world study. Scientific Reports 13:1.
Crossref
Crossref
Eugen Trinka, Taoufik Alsaadi, Hiroko Goji, Taketoshi Maehara, Satoru Takahashi, Julia Jacobs, Rosaria Renna, Francisco José Gil‐López, Rob McMurray, Ricardo Sáinz‐Fuertes & Vicente Villanueva. (2023) Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practice. Epilepsia 64:8, pages 2094-2107.
Crossref
Crossref
Claudio Liguori, Estevo Santamarina, Adam Strzelczyk, Juan Jesús Rodríguez-Uranga, Rohit Shankar, Xiana Rodríguez-Osorio, Stéphane Auvin, Paolo Bonanni, Eugen Trinka, Rob McMurray, Ricardo Sáinz-Fuertes & Vicente Villanueva. (2023) Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT study. Frontiers in Neurology 14.
Crossref
Crossref
Yotin Chinvarun, Rafael Toledano Delgado, Alexandra Astner-Rohracher, Tim Wehner, Manuel Toledo, Sara Matricardi, Eugen Trinka, Manoj Malhotra, Oliver Shastri & Vicente Villanueva. (2023) Perampanel Monotherapy for Focal and Generalized Epilepsy in Clinical Practice. Acta Neurologica Scandinavica 2023, pages 1-12.
Crossref
Crossref
Daniela Silva, Ruben Rocha, Ana Salomé Correia, Bárbara Mota, Maria Dulce Madeira, Nuno Vale & Armando Cardoso. (2022) Repurposed Edaravone, Metformin, and Perampanel as a Potential Treatment for Hypoxia–Ischemia Encephalopathy: An In Vitro Study. Biomedicines 10:12, pages 3043.
Crossref
Crossref
Wendyl D'Souza, Taoufik Alsaadi, Javier Montoya, Mar Carreño, Carlo Di Bonaventura, Rajiv Mohanraj, Takamichi Yamamoto, Rob McMurray, Oliver Shastri & Vicente Villanueva. (2022) Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study. Seizure: European Journal of Epilepsy 100, pages 56-66.
Crossref
Crossref
Vicente Villanueva, Wendyl D’Souza, Hiroko Goji, Dong Wook Kim, Claudio Liguori, Rob McMurray, Imad Najm, Estevo Santamarina, Bernhard J. Steinhoff, Pavel Vlasov, Tony Wu & Eugen Trinka. (2021) PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice. Journal of Neurology 269:4, pages 1957-1977.
Crossref
Crossref
Yi-On Fong, Poyin Huang, Chung Yao Hsu & Yuan-Han Yang. (2022) Effects of Perampanel on Seizure Control, Cognition, Behavior, and Psychological Status in Patients With Epilepsy: A Systematic Review. Journal of Clinical Neurology 18:6, pages 653.
Crossref
Crossref
Andrea Macrelli, Nicolò Simone Villa, Andrea Lucotti, David Dellasega, Paolo Maria Ossi & Matteo Tommasini. (2021) Sensing the Anti-Epileptic Drug Perampanel with Paper-Based Spinning SERS Substrates. Molecules 27:1, pages 30.
Crossref
Crossref
Jeremy M. Henley, Jithin D. Nair, Richard Seager, Busra P. Yucel, Gavin Woodhall, Benjamin S. Henley, Karolina Talandyte, Hope I. Needs & Kevin A. Wilkinson. (2021) Kainate and AMPA receptors in epilepsy: Cell biology, signalling pathways and possible crosstalk. Neuropharmacology 195, pages 108569.
Crossref
Crossref
Ranran Zhang, Shan Qiao, Xiqin Fang, Kemo Wang, Yanting Shi, Qianwen Du, Tingting Yang & Xuewu Liu. (2021) Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study. Frontiers in Neurology 12.
Crossref
Crossref
Angelo Pascarella, Luigi Francesco Iannone, Giancarlo Di Gennaro, Alfredo D'Aniello, Edoardo Ferlazzo, Nazareno Gagliostro, Francesco Ursini, Paolo Bonanni, Nicola Paciello, Andrea Romigi, Umberto Aguglia, Giovambattista De Sarro, Emilio Russo, Antonio Gambardella & Angelo Labate. (2020) The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy. Journal of the Neurological Sciences 415, pages 116903.
Crossref
Crossref
Saeid Charsouei, M. Reza Jabalameli & Amin Karimi-Moghadam. (2020) Molecular insights into the role of AMPA receptors in the synaptic plasticity, pathogenesis and treatment of epilepsy: therapeutic potentials of perampanel and antisense oligonucleotide (ASO) technology. Acta Neurologica Belgica 120:3, pages 531-544.
Crossref
Crossref
Andras Fogarasi, Robert Flamini, Mathieu Milh, Steven Phillips, Shinsaku Yoshitomi, Anna Patten, Takao Takase, Antonio Laurenza & Leock Y. Ngo. (2020) Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic‐clonic seizures. Epilepsia 61:1, pages 125-137.
Crossref
Crossref
Javier Abril Jaramillo, José Carlos Estévez María, Juan Miguel Girón Úbeda, Óscar Vega López, María Elena Calzado Rivas, Hernando Pérez Díaz, Guillermina García Martín, Elena Vila Herrero, M. Chamorro-Muñoz, F. Vázquez, C. De la Fuente, L. Redondo, N. Peláez, Patricia Santágueda & Juan Jesús Rodríguez Uranga. (2020) Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON). Epilepsy & Behavior 102, pages 106655.
Crossref
Crossref
Lai, Tzeng, Huang & Wu. (2019) The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-type Potassium Currents. Biomolecules 9:10, pages 638.
Crossref
Crossref